US Stock MarketDetailed Quotes
ESPR Esperion Therapeutics
- 2.540
- -0.030-1.17%
Close Nov 27 16:00 ET
- 2.490
- -0.050-1.96%
Post 19:39 ET
500.47MMarket Cap-3791P/E (TTM)
2.610High2.460Low5.32MVolume2.590Open2.570Pre Close13.43MTurnover2.72%Turnover RatioLossP/E (Static)197.04MShares3.40052wk High-1.35P/B496.90MFloat Cap1.34552wk Low--Dividend TTM195.63MShs Float120.960Historical High--Div YieldTTM5.84%Amplitude0.700Historical Low2.522Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Esperion Therapeutics Stock Forum
someone loaded 520k at close 👀👀👀👀
Esperion Highlights New Exploratory Data from CLEAR Outcomes Trial Highlighting Value of NEXLETOL® (bempedoic acid) in Oral Featured Science Session and Multiple Poster Presentations at AHA Scientific Sessions 2024
Esperion (ESPR) presented new exploratory data from the CLEAR Outcomes trial at the 2024 AHA Scientific Sessions, highlighting significant benefits of NEXLETOL (bempedoic acid).
The analysis showed patients with Peripheral Artery Disease (PAD) tak...
Hugely Undervalued $2 Biotech With 21% Held Short $16 Price Target, Takeover Candidate, Soon Profitable. Fund that owns $Viking Therapeutics (VKTX.US)$ since 2022 below $10 a share is also investing in ESPR and expects the company will be a block buster.
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esper...
No comment yet